RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer

被引：0
|
作者：
Yueyue Yang
Jiafei Lin
Susu Guo
Xiangfei Xue
Yikun Wang
Shiyu Qiu
Jiangtao Cui
Lifang Ma
Xiao Zhang
Jiayi Wang
机构：
[1] Shanghai Tenth People’s Hospital of Tongji University,Department of Clinical Laboratory
[2] Ruijin Hospital,Department of Clinical Laboratory
[3] Shanghai Jiao Tong University School of Medicine,Shanghai Institute of Thoracic Oncology
[4] Shanghai Chest Hospital,Department of Thoracic Surgery
[5] Shanghai Jiao Tong University,undefined
[6] Shanghai Institute of Thoracic Tumors,undefined
[7] Shanghai Chest Hospital,undefined
[8] Shanghai Jiao Tong University,undefined
来源：
Cancer Cell International | / 20卷
关键词：
GSS; Proteasome; Diagnosis; Phosphorylation; Glutathione; Erastin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer
    Yang, Yueyue
    Lin, Jiafei
    Guo, Susu
    Xue, Xiangfei
    Wang, Yikun
    Qiu, Shiyu
    Cui, Jiangtao
    Ma, Lifang
    Zhang, Xiao
    Wang, Jiayi
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [2] Celastrol induces ferroptosis by suppressing RRM2 in hepatocellular carcinoma
    Zhang, Xue
    Qi, Manman
    Huo, Kailun
    Cai, Banglan
    Zhang, Jian
    Tian, Yijun
    Zhang, Denghai
    HELIYON, 2024, 10 (13)
  • [3] Identification of RRM2 as a key ferroptosis-related gene in sepsis
    He, Shasha
    He, Yidong
    Deng, Liyan
    Guo, Yuhong
    Wang, Xiaopeng
    Wang, Qian
    Luo, Lianxiang
    Liu, Qingquan
    INFLAMMATION RESEARCH, 2024, 73 (03) : 459 - 473
  • [4] Identification of RRM2 as a key ferroptosis-related gene in sepsis
    Shasha He
    Yidong He
    Liyan Deng
    Yuhong Guo
    Xiaopeng Wang
    Qian Wang
    Lianxiang Luo
    Qingquan Liu
    Inflammation Research, 2024, 73 : 459 - 473
  • [5] RRM2 is a potential prognostic biomarker with functional significance in glioma
    Sun, Hongzhi
    Yang, Bingya
    Zhang, Hao
    Song, Jingwei
    Zhang, Yenan
    Xing, Jicheng
    Yang, Zhihui
    Wei, Changyong
    Xu, Tuoye
    Yu, Zhennan
    Xu, Zhipeng
    Hou, Min
    Ji, Minjun
    Zhang, Yansong
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (03): : 533 - 543
  • [6] Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death
    Tang, Bufu
    Xu, Wangting
    Wang, Yajie
    Zhu, Jinyu
    Wang, Hailin
    Tu, Jianfei
    Weng, Qiaoyou
    Kong, Chunli
    Yang, Yang
    Qiu, Rongfang
    Zhao, Zhongwei
    Xu, Min
    Ji, Jiansong
    CLINICAL IMMUNOLOGY, 2021, 232
  • [7] RRM1 AND RRM2 GENE POLYMORPHISMS IN PATIENTS WITH PRIMARY OVARIAN CANCER
    Attar, Rukset
    Yildirim, Gazi
    Ficicioglu, Cem
    Gulec-Yilmaz, Seda
    Timirci-Kahraman, Ozlem
    Atasoy, Hande
    Yildirim, Ozge Kizilkale
    Iyibozkurt, Cem
    Buyukoren, Ahmet
    Dalan, Altay Burak
    Yaylim, Ilhan
    Gormus, Uzay
    Isbir, Turgay
    ANTICANCER RESEARCH, 2014, 34 (10) : 5966 - 5967
  • [8] HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas
    Huaxin Zhu
    Jiacong Tan
    Xinyi Pan
    Hengyang Ouyang
    Zhixiong Zhang
    Meihua Li
    Yeyu Zhao
    BMC Cancer, 23
  • [9] HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas
    Zhu, Huaxin
    Tan, Jiacong
    Pan, Xinyi
    Ouyang, Hengyang
    Zhang, Zhixiong
    Li, Meihua
    Zhao, Yeyu
    BMC CANCER, 2023, 23 (01)
  • [10] Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
    Ohmura, Shunya
    Marchetto, Aruna
    Orth, Martin F.
    Li, Jing
    Jabar, Susanne
    Ranft, Andreas
    Vinca, Endrit
    Ceranski, Katharina
    Carreno-Gonzalez, Martha J.
    Romero-Perez, Laura
    Wehweck, Fabienne S.
    Musa, Julian
    Bestvater, Felix
    Knott, Maximilian M. L.
    Hoelting, Tilman L. B.
    Hartmann, Wolfgang
    Dirksen, Uta
    Kirchner, Thomas
    Cidre-Aranaz, Florencia
    Grunewald, Thomas G. P.
    MOLECULAR CANCER, 2021, 20 (01)
12345